Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or North Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to North Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. North Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Rachel Tedesco (NPI 1063056687)

Field	Value
Entity Type	Individual
Organization	Rachel Tedesco
Address	44 Mcneill Plz
City	Whiteville
State	NC
ZIP	28472
Taxonomy	Nurse Practitioner
NPI Enumerated	November 6, 2019

Payer Source	Total Paid
Medicare	$5.7M
Medicaid	$0

Key Findings

The provider’s Medicare book of business is dominated by high-cost injectable biologics and monoclonal antibody products, indicating an infusion/injection-focused outpatient practice model. Top-revenue drugs on the list include J3380, J3245, J2350 and J0897, and the presence of numerous J-codes for specialty biologics suggests regular, clinic-administered dosing for chronic conditions rather than primarily office evaluation-and-management visits.

Revenue concentration is high: the precomputed top-three Medicare codes account for 43.0% of this provider’s total Medicare revenue, and the practice has generated $5.7M in Medicare revenue over its lifetime. The three leading codes by revenue are J3380 ($912.9K), J3245 ($828.4K), and J2350 ($731.4K), which together drive a large share of the provider’s Medicare receipts.

Payer mix is effectively single-payer Medicare: Total Medicare revenue is $5.7M while Total Medicaid revenue is none (no Medicaid billing on file), so the provider’s publicly observed revenue depends entirely on Medicare billing activity. This concentration means analyses of utilization and business risk should focus on Medicare payment and utilization changes.

Several individual codes show exceptional national standing, signaling a market-leading role for specific products. J3380 ranks #2 of 620 providers nationally (100th percentile; extreme outlier), J0897 ranks #78 of 10057 providers (99th percentile; extreme outlier), and J0517 ranks #8 of 200 providers nationally (96th percentile; notably above typical national volume), which together indicate this provider is an unusually large dispenser/administrator for multiple specialty injectables.

Infusion and administration activity is also elevated, supporting the interpretation of a high-throughput infusion service line. Codes for administration such as 96372 (1.5K claims) rank #138 of 58224 providers (100th percentile; extreme outlier) and 96365 (861 claims) ranks #124 of 8873 providers (99th percentile; notably above typical national volume), indicating substantial procedural throughput beyond drug billing alone.

The provider’s revenue mix shows both concentration and some diversification within injectable therapies: while the top three codes are a large share (43.0%), additional J-codes such as J2357, J3111, J1569, and J2182 each contribute meaningful but smaller slices to the $5.7M Medicare total. This profile reduces reliance on a single molecule somewhat, but still exposes the practice to shifts in utilization or reimbursement for several high-impact biologics.

The NPI was enumerated on 2019-11-06 (~7 years ago), so this profile reflects substantial scale-up in a relatively short tenure. Generating $5.7M of Medicare revenue since enumeration suggests rapid adoption of high-cost injectable administration workflows and successful capture of Medicare infusion volumes.

Clinical breadth extends beyond a single specialty: the code mix includes immunology/biologics (e.g., J3245, J2350, J2182), osteoporosis or bone agents (J0897, J3111), immune globulin therapy (J1569), and even chemotherapy administration codes (96413, 96415, 96401) present at modest volumes. These signals imply a multi-therapy infusion service capable of delivering a range of specialty injectable treatments, though each non-top code remains lower-revenue relative to the leading biologics.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

23 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3380	Injection, vedolizumab, intravenous, 1 mg	53,700	$20	$912.9K
J3245	Injection, tildrakizumab, 1 mg	7,600	$110	$828.4K
J2350	Injection, ocrelizumab, 1 mg	15,900	$50	$731.4K
J0897	Injection, denosumab, 1 mg	33,600	$20	$604.8K
J0517	Injection, benralizumab, 1 mg	3,810	$130	$502.9K
J2357	Injection, omalizumab, 5 mg	14,000	$30	$419.9K
J3111	Injection, romosozumab-aqqg, 1 mg	49,770	$10	$398.2K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	10,140	$40	$365K
J2182	Injection, mepolizumab, 1 mg	13,400	$20	$308.2K
J1306	Injection, inclisiran, 1 mg	30,390	$10	$273.5K

Showing 1–10 of 23

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. North Carolina Distribution

Rachel Tedesco — 9 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — North Carolina

Full comparison — all codes billed, vs. state median

23 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3245	2	10	3,400	$110	$640.2K
J2350	2	10	11,550	$40	$445.6K
J2356	4	10	19,950	$10	$276K
J2182	2	10	11,950	$20	$239.8K
J0517	1	10	840	$130	$222.3K
J3380	1	30	6,300	$20	$171.4K
J3111	2	30	13,970	$10	$135.8K
J1569	2	10	2,880	$40	$130.8K
J2357	1	20	2,850	$30	$127.5K
J1745	26	80	4,110	$30	$117.3K

Showing 1–10 of 23

Related Providers

Other providers that share a Tax Identification Number (TIN) with Rachel Tedesco, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Palmetto Infusion Services LLC	SC	Infusion Therapy Clinic/Center	$0	$93.6M
Kristi Hunter	GA	General Practice Physician	$6.4M	$0
Stephen Parks	SC	Family Medicine Physician	$3.9M	$0
Lindsay Gamble	SC	Family Nurse Practitioner	$3.7M	$0
Lisa Sauls	SC	Family Nurse Practitioner	$3.4M	$0
Rosalee Unwin	SC	Family Nurse Practitioner	$2.9M	$0
Whitley Weatherford	SC	Family Nurse Practitioner	$2.7M	$0
Glenda Collins	SC	Family Nurse Practitioner	$2.3M	$0
James Montgomery	SC	Gynecology Physician	$1.9M	$0
Eliza Shinall	GA	Family Nurse Practitioner	$1.5M	$0

Nearby Providers

Other providers in the same ZIP code as Rachel Tedesco, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Community Innovations	NC	Community/Behavioral Health Agency	$0	$73.8M
Carolinas Home Care Agency, Inc.	NC	Community/Behavioral Health Agency	$0	$45.9M
Advantage Behavioral Healthcare Inc.	NC	Mental Health Counselor	$0	$20.1M
Columbus Regional Healthcare System	NC	General Acute Care Hospital	$0	$17.2M
Homecare Management Corporation	NC	Community/Behavioral Health Agency	$0	$16.8M
Interim Healthcare Of The Eastern Carolinas, Inc	NC	In Home Supportive Care Agency	$0	$10.9M
Jeffrey Coury	NC	Facial Plastic Surgery Physician	$508.5K	$0
Rene Bermudez	NC	MOHS-Micrographic Surgery Physician	$460.6K	$0
David Sutton	NC	Ophthalmology Physician	$437.5K	$6.7K
Columbus County Ems, Inc	NC	Land Ambulance	$327.6K	$110.8K

Rachel Tedesco — Billing Profile & Reimbursement Data

Sign up for Rachel Tedesco — Billing Profile & Reimbursement Data policy alerts

Rachel Tedesco — Billing Profile & Reimbursement Data

Sign up for Rachel Tedesco — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References